Literature DB >> 16699465

Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept.

Denis Dufrane1, Rose-Marie Goebbels, Alain Saliez, Yves Guiot, Pierre Gianello.   

Abstract

BACKGROUND: Pig islets xenotransplantation remains associated with a strong humoral and cellular xenogeneic immune responses. The aim of this study was to assess the long-term biocompatibility of alginate encapsulated pig islets after transplantation in primates.
METHODS: Adult pig islets encapsulated in alginate under optimal conditions (n=7) or not (n=5) were transplanted under the kidney capsule of nondiabetic Cynomolgus maccacus. Additional primates received empty capsules (n=1) and nonencapsulated pig islets (n=2) as controls. Capsule integrity, cellular overgrowth, pig islet survival, porcine C-peptide and anti-pig IgM/IgG antibodies were examined up to 6 months after implantation.
RESULTS: Nonencapsulated islets and islets encapsulated in nonoptimal capsules were rapidly destroyed. In seven primates receiving perfectly encapsulated pig islets, part of the islets survived up to 6 months after implantation without immunosuppression. Porcine C-peptide was detected after 1 month in 71% of the animals. The majority of grafts (86%) were intact and completely free of cellular overgrowth or capsule fibrosis. Explanted capsules, after 135 (n=2/2) and 180 (n=2/3) days, demonstrated residual insulin content and responses to glucose challenge (stimulation index of 2.2). Partial islet survival was obtained despite an elicited anti-pig IgG humoral response.
CONCLUSIONS: Optimal alginate encapsulation significantly prolonged adult pig islet survival into primates for up to 6 months, even in the presence of antibody response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699465     DOI: 10.1097/01.tp.0000208610.75997.20

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  59 in total

Review 1.  Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain.

Authors:  Esther S O'Sullivan; Arturo Vegas; Daniel G Anderson; Gordon C Weir
Journal:  Endocr Rev       Date:  2011-09-27       Impact factor: 19.871

2.  Hyaluronic Acid/Collagen Hydrogel as an Alternative to Alginate for Long-Term Immunoprotected Islet Transplantation<sup/>.

Authors:  Stephen Harrington; Janette Williams; Sonia Rawal; Karthik Ramachandran; Lisa Stehno-Bittel
Journal:  Tissue Eng Part A       Date:  2017-03-02       Impact factor: 3.845

Review 3.  Challenges and emerging technologies in the immunoisolation of cells and tissues.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

Review 4.  Pig-to-Primate Islet Xenotransplantation: Past, Present, and Future.

Authors:  Zhengzhao Liu; Wenbao Hu; Tian He; Yifan Dai; Hidetaka Hara; Rita Bottino; David K C Cooper; Zhiming Cai; Lisha Mou
Journal:  Cell Transplant       Date:  2017-02-03       Impact factor: 4.064

5.  Xenotransplantation as a model of integrated, multidisciplinary research.

Authors:  Emanuele Cozzi; Erika Bosio; Michela Seveso; Domenico Rubello; Ermanno Ancona
Journal:  Organogenesis       Date:  2009-01       Impact factor: 2.500

Review 6.  Design of a bioartificial pancreas.

Authors:  Rajesh A Pareta; Alan C Farney; Emmanuel C Opara
Journal:  Pathobiology       Date:  2013-05-06       Impact factor: 4.342

Review 7.  Controlled delivery systems: from pharmaceuticals to cells and genes.

Authors:  Elizabeth Rosado Balmayor; Helena Sepulveda Azevedo; Rui L Reis
Journal:  Pharm Res       Date:  2011-03-19       Impact factor: 4.200

Review 8.  Macro- or microencapsulation of pig islets to cure type 1 diabetes.

Authors:  Denis Dufrane; Pierre Gianello
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 9.  Can We Re-Engineer the Endocrine Pancreas?

Authors:  Antonio Citro; Harald C Ott
Journal:  Curr Diab Rep       Date:  2018-10-02       Impact factor: 4.810

Review 10.  Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices.

Authors:  Shang Song; Shuvo Roy
Journal:  Biotechnol Bioeng       Date:  2016-01-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.